AINGENS
AINGENS (Columbia, MD) is a private life sciences AI software firm operating MACg, an evidence-first AI platform with PubMed-integrated RAG for medical writers, researchers, and pharma/biotech teams. Revenue comes from tiered subscriptions ($20–$129/month), pay-per-use credits, storage add-ons, and custom enterprise agreements.
- Company typePrivate
- Founded2024
- HeadquartersColumbia, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What AINGENS does
AINGENS, LLC is a privately held software company headquartered in Columbia, Maryland, founded in 2024 to develop AI-powered content creation tools for life sciences professionals. Its flagship product, MACg (Medical Affairs Content Generator), is an evidence-first platform that integrates PubMed literature search (accessing 30+ million citations and 37 million research articles), AI-assisted writing, automated citation generation in AMA, APA, and MLA formats, reference management, scientific visualization, and presentation generation within a single workflow. The platform is built on OpenAI's GPT-4, GPT-5, and o3-mini models using a Retrieval-Augmented Generation (RAG) architecture intended to ground outputs in verified scientific literature, with subcomponents including Ask MACg (an AI medical writer), a PubMed search tool, a Word-like text editor with cite-as-you-write, AMA/APA/MLA citation generators, and a Scientific Slide Presentation Generator. A Clinical AI Reliability Test published in 2026 claimed zero hallucinations and 100% accuracy on clinical data extraction across five peer-reviewed publications.
The company monetizes through tiered subscriptions ($20 Starter, $49 Pro, $99 Pro Plus, $129 per-seat Team), pay-per-use AI credits (500,000 credits for $5), storage add-ons ($5 per GB per month), and custom-priced enterprise agreements with optional multi-year contracts, supplemented by an affiliate program offering 30% recurring commissions. Customer segments include individual medical writers and healthcare bloggers, pharmaceutical and biotechnology firms, research and clinical organizations, healthcare content agencies, and students. Enterprise deployment options include private cloud installation on AWS, Azure, or Google Cloud with SSO, custom LLM selection, and domain training. SOC 2 Type II and ISO 27001 certifications, GDPR compliance, and an explicit no-training-on-customer-data policy underpin the platform's positioning for regulated life sciences environments.
AINGENS is led by founder and CEO Ome Ogbru, PharmD, with a 1–10 person team and no disclosed external funding. Distribution combines self-serve online subscriptions with enterprise field sales, supported by content marketing, SEO, an affiliate program, industry event presence, and earned media. Strategic partnerships include OpenAI (foundation model provider), AWS (cloud infrastructure), and JOTO PR Disruptors™ (marketing), with enterprise software integrations spanning Veeva Vault, SharePoint, and EMBASE.
AINGENS firmographics
Firmographics- Name
- AINGENS
- Legal name
- AINGENS, LLC
- Website
- https://aingens.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AINGENS (Columbia, MD) is a private life sciences AI software firm operating MACg, an evidence-first AI platform with PubMed-integrated RAG for medical writers, researchers, and pharma/biotech teams. Revenue comes from tiered subscriptions ($20–$129/month), pay-per-use credits, storage add-ons, and custom enterprise agreements.
- Ownership category
- akta.pro rank
AINGENS industry classification
Industry- Product category
- Life Sciences AI Writing Software
- NAICS
- Software Publishers (5132), Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
Keywords
Where AINGENS is headquartered
LocationHeadquarters
- HQ city
- Columbia
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AINGENS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription Plans: Monthly and annual subscription tiers (Starter, Pro, Pro Plus, Team) providing recurring revenue with tiered access to platform features. Annual plans offer cost savings compared to monthly billing.
- Usage-Based Credits: Credit-based consumption model where users purchase additional AI credits (500,000 credits for $5) beyond their tier allocation. Enables variable revenue based on usage intensity.
- Enterprise Licensing: Custom-priced enterprise agreements for large organizations requiring advanced features, enhanced security, and dedicated support.
- Affiliate Program: Partner referral program offering 30% recurring commission for affiliates who refer new subscribers, driving customer acquisition through community and influencer channels.
- Storage Add-ons: Additional storage capacity available at $5 per GB per month, providing supplementary revenue from power users requiring extensive document and reference storage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Starter plan for individual users |
| Subscription | Monthly | Pro plan for professional medical writers |
| Subscription | Monthly | Pro Plus plan for power users |
| Per seat | Monthly | Team plan for collaborative groups |
| Subscription | Multi-year contract | Enterprise plan for large organizations |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
AINGENS product offering
Product offeringCore offering
AINGENS develops and sells MACg (Medical Affairs Content Generator), an AI-powered scientific writing and research SaaS platform that integrates PubMed literature search, automated AMA/APA/MLA citation generation, an AI text editor, scientific slide presentation generation, and data visualization into a single evidence-first workflow. Customers include individual medical writers, healthcare agencies, pharmaceutical and biotechnology medical affairs teams, and academic researchers who subscribe via tiered monthly subscriptions or custom enterprise contracts.
Product overview
AINGENS offers MACg (Medical Affairs Content Generator), a unified AI-powered platform designed specifically for life sciences content creation. The platform integrates multiple tools: Ask MACg (AI medical writer), PubMed search, Reference Manager, Citation Generator (AMA/APA/MLA), Advanced Text Editor, Scientific Slide Presentation Generator, and Image/Diagram/Chart visualization tools. MACg replaces six or more separate AI subscriptions for medical writing, research, medical information, and slide presentations. The platform uses retrieval-augmented generation (RAG) with OpenAI GPT models to ensure evidence-backed content with zero hallucinations. Enterprise deployment options include private cloud installation, custom LLM selection, and domain training. A companion Affiliate Program offers 30% recurring commissions for partners.
Differentiator
Problem solved
Functional benefit
Brands
- MACg: Medical Affairs Content Generator - an AI-powered scientific writing and research platform for life sciences professionals, featuring PubMed integration, citation generation, slide presentation tools, and evidence-based content creation workflows.
Products and services
- MACg (Medical Affairs Content Generator) Evidence-first AI-powered scientific writing and research SaaS platform that combines PubMed search, automated AMA/APA/MLA citation generation, an AI writing editor, scientific visualization, and slide presentation capabilities into a single workflow for medical writers, healthcare agencies, pharma/biotech teams, and academic researchers.
- MACg Enterprise Enterprise deployment option for MACg offering private cloud installation on AWS, Azure, or Google Cloud, unlimited teams, custom LLM selection, domain training, custom prompts and templates, SSO, dedicated support, and integration with Veeva, SharePoint, and EMBASE for pharma/biotech medical affairs, regulatory, and compliance workflows.
Quantifiable outcome
- Hours saved per medical writing project through automated citation and evidence search
Companies that use AINGENS
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
AINGENS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability8 records
Feature5 records
AINGENS partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- JOTO PR Disruptors™coreStrategic marketing partnership to promote evidence-first AI workflow infrastructure for life sciences. Joint efforts to increase brand awareness and market positioning within the medical writing and healthcare communications industry.
- OpenAIcoreTechnology partnership providing access to GPT-4, GPT-5, and o3-mini language models powering AINGENS AI capabilities. OpenAI provides the underlying large language models used for scientific content generation.
- AWS (Amazon Web Services)coreCloud infrastructure partnership providing scalable computing resources, data storage, and platform reliability. AWS hosts the platform and enables global accessibility.
Scale indicators2 records
Recent moves5 records
Expansion highlights6 records
AINGENS competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AINGENS social profiles
Digital presenceAINGENS compliance and trust
Trust signalCompliance3 records
AINGENS financial estimates
Financial estimateRevenue estimate
Valuation estimate
AINGENS leadership team
Management profileNumber of profiles
Profiles1 record
AINGENS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AINGENS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AINGENS
What does AINGENS do?
AINGENS develops and sells MACg (Medical Affairs Content Generator), an AI-powered scientific writing and research SaaS platform that integrates PubMed literature search, automated AMA/APA/MLA citation generation, an AI text editor, scientific slide presentation generation, and data visualization into a single evidence-first workflow. Customers include individual medical writers, healthcare agencies, pharmaceutical and biotechnology medical affairs teams, and academic researchers who subscribe via tiered monthly subscriptions or custom enterprise contracts.
Is AINGENS a public or private company?
AINGENS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AINGENS founded?
AINGENS was founded in 2024. It employs 1 to 10 people.
Where is AINGENS based?
AINGENS is headquartered in Columbia, United States, in the North America region.
How does AINGENS make money?
Five revenue lines are on record. Subscription Plans are the primary driver. The others are usage-Based Credits, enterprise Licensing, affiliate Program and storage Add-ons.
Does AINGENS have an API?
No public API is recorded for AINGENS.
What industry is AINGENS in?
AINGENS's product category is Life Sciences AI Writing Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 5132 and its SIC code is 7372.